The cadherin switch in ovarian high-grade serous carcinoma is associated with disease progression

Virchows Archiv

Volumn 459, Issue 1, 2011, Pages 21-29

  Quattrocchi, Livia ^a   Green, Andrew R ^b   Martin, Stewart ^b   Durrant, Lindy ^b   Deen, Suha ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Cadherin; Cancer; Metastasis; Ovary

Indexed keywords

NERVE CELL ADHESION MOLECULE; P CADHERIN; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STAGING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARIAN HIGH GRADE SEROUS CARCINOMA; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION;

EID: 85027921689     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-011-1082-1     Document Type: Article

References (24)

1. TJ Duncan P Rolland S Deen IV Scott DT Liu I Spendlove, et al. 2007 Loss of IFN gamma receptor is an independent prognostic factor in ovarian cancer Clin Cancer Res 13 4139 4145 17634541 10.1158/1078-0432.CCR-06-2833 1:CAS:528:DC%2BD2sXnvVChsro%3D (Pubitemid 47105976)
2. S Elloul I Silins CG Tropé A Benshushan B Davidson R Reich 2006 Expression of E-cadherin transcriptional regulators in ovarian carcinoma Virchows Arch 449 520 528 17024425 10.1007/s00428-006-0274-6 1:CAS:528:DC%2BD28XhtFylt77F (Pubitemid 44722320)
3. U Jeschke I Mylonas C Kuhn N Shabani C Kunert-Keil C Schindlbeck B Gerber K Friese 2007 Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence Anticancer Res 27 4A 1969 1974 17649807 1:CAS:528:DC%2BD2sXotVCqsL0%3D (Pubitemid 46954710)
4. LG Hudson R Zeineldin MS Stack 2008 Phenotypic plasticity of neoplastic ovarian epithelium: unique cadherin profiles in tumor progression Clin Exp Metastasis 25 643 655 18398687 10.1007/s10585-008-9171-5 1:CAS:528: DC%2BD1cXhtVeisL7K
5. K Tomita A van Bokhoven GJ van Leenders, et al. 2000 Cadherin switching in human prostate cancer progression Cancer Res 60 3650 3654 10910081 1:CAS:528:DC%2BD3cXkvFChtrw%3D (Pubitemid 30482189)
6. RB Hazan GR Phillips RF Qiao L Norton SA Aaronson 2000 Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis J Cell Biol 148 779 790 10684258 10.1083/jcb.148.4.779 1:CAS:528:DC%2BD3cXhsVOqsLw%3D [Erratum appears in J Cell Biol 2000;149:following 236]
7. S Nakajima R Doi E Toyoda, et al. 2004 N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma Clin Cancer Res 10 12 Pt 1 4125 4133 15217949 10.1158/1078-0432.CCR-0578-03 1:CAS:528: DC%2BD2cXltFWmu78%3D (Pubitemid 38812492)
8. MJG Bussemakers A Van Bokhoven K Tomita CFJ Jansen JA Schalken 2000 Complex cadherin expression in human prostate cancer cells Int J Cancer 85 446 450 10652439 10.1002/(SICI)1097-0215(20000201)85:3<446::AID-IJC23>3.0. CO;2-B 1:CAS:528:DC%2BD3cXmsVCntg%3D%3D (Pubitemid 30030421)
9. C Wu J Cipollone S Maines-Bandiera, et al. 2008 The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression Differentiation 76 193 205 17608733 10.1111/j.1432-0436.2007.00193.x 1:CAS:528:DC%2BD1cXivFersbw%3D (Pubitemid 351197172)
10. IS Patel P Madan S Getsios MA Bertrand CD MacCalman 2003 Cadherin switching in ovarian cancer progression Int J Cancer 106 172 177 12800191 10.1002/ijc.11086 1:CAS:528:DC%2BD3sXlvV2qsbg%3D (Pubitemid 36835168)
11. J Paredes A Albergaria JT Oliveira C Jerónimo F Milanezi FC Schmitt 2005 P-cadherin over expression is an indicator of clinical outcome in invasive breast carcinomas and is associated with CDH3 promoter hypomethylation Clin Cancer Res 11 5869 5877 16115928 10.1158/1078-0432.CCR-05-0059 1:CAS:528:DC%2BD2MXos1Cjur8%3D (Pubitemid 41170315)
12. A Peralta Soler KA Knudsen H Salazar AC Han AA Keshgegian 1999 P-cadherin expression in breast carcinoma indicates poor survival Cancer 86 1263 1272 10506713 10.1002/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2 1:STN:280:DyaK1MvjvVChug%3D%3D (Pubitemid 29447011)
13. D Sarrió J Palacios M Hergueta-Redondo G Gómez-López A Cano G Moreno-Bueno 2009 Functional characterization of E- and P-cadherin in invasive breast cancer cells BMC Cancer 9 74 19257890 10.1186/1471-2407-9-74
14. EA Eisenhauer P Therasse J Bagaerts LH Schwartz D Sargent R Ford, et al. 2009 New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1) Eur J Cancer 45 228 247 19097774 10.1016/j.ejca.2008.10.026 1:STN:280:DC%2BD1M%2Fgs12rug%3D%3D
15. J Kononen L Bubendorf A Kallioniemi, et al. 1998 Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 844 847 9662379 10.1038/nm0798-844 1:CAS:528:DyaK1cXktlKntr8%3D (Pubitemid 28331029)
16. RL Camp LA Charette DL Rimm 2000 Validation of tissue microarray technology in breast carcinoma Lab Invest 80 12 1943 1949 11140706 10.1038/labinvest.3780204 1:STN:280:DC%2BD3M%2Foslamsg%3D%3D (Pubitemid 32012762)
17. D Shibata YS Fu JW Gupta KV Shah J Martin N Arnheim 1988 Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology Can Res 48 4564 4566 1:CAS:528:DyaL1cXlt1Ghsr8%3D
18. KS McCarty Jr LS Miller EB Cox J Konrath KS McCarty Sr 1985 Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies Arch Pathol Lab Med 109 716 721 3893381 (Pubitemid 16237466)
19. G Daniel XH Rosen MT Deavers, et al. 2004 Validation of tissue microarray technology in ovarian carcinoma Mod Pathol 17 790 797 10.1038/modpathol.3800120 (Pubitemid 38843361)
20. RL Camp M Dolled-Filhart DL Rimm 2004 X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252 7259 15534099 10.1158/1078-0432.CCR-04-0713 1:CAS:528: DC%2BD2cXpsVKltbc%3D (Pubitemid 39487712)
21. C Faleiro-Rodrigues I MacEdo-Pinto D Pereira VM Ferreira CS Lopes 2004 Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas Hum Pathol 35 663 669 15188131 10.1016/j.humpath.2004.01.024 1:CAS:528:DC%2BD2cXkslWlsrg%3D (Pubitemid 38881075)
22. Y Kuwabara T Yamada K Yamazaki, et al. 2008 Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis Cancer Sci 99 1933 1939 19016752 1:CAS:528:DC%2BD1cXhsVGlsbbL
23. K Sundfeldt Y Piontkewitz K Ivarsson, et al. 1997 E-cadherin expression in human epithelial ovarian cancer and normal ovary Int J Cancer 74 275 280 9221804 10.1002/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W 1:STN:280:DyaK2szmsVymtw%3D%3D (Pubitemid 27321795)
24. S Islam TE Carey GT Wolf MJ Wheelock KR Johnson 1996 Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion J Cell Biol 135 6 Pt 1 1643 1654 8978829 10.1083/jcb.135.6.1643 1:CAS:528:DyaK28XnsFGltLg%3D (Pubitemid 26427658)